Clinical Trial Update: Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

This update reports on a Phase 4 study examining how vildagliptin influences the glucagon response to hypoglycemia in insulin-treated patients with type 2 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Lund University | Conditions: Diabetes | Phase 4 | Status: COMPLETED